Providing meaningful survival benefit to hepatocellular carcinoma patients: combination therapy of future

Hepatobiliary Surg Nutr. 2022 Oct;11(5):779-781. doi: 10.21037/hbsn-22-322.

Author

Devanand Sarkar¹

Affiliation

¹ Department of Human and Molecular Genetics, Massey Cancer Center and VCU Institute of Molecular Medicine (VIMM), Virginia Commonwealth University, Richmond, VA, USA.

No abstract available

Publication types

Editorial
Comment

Grants and funding